[The correction of immunity in adolescents and children with focal staphylococcal diseases].
The aim of the work done was to improve treatment options for focal Staphylococcus-induced diseases in adolescents and children with the aid of adsorbed staphylococcal anatoxin (ASA) concurrently with low-intensive EHF therapy. Overall fifty patients aged 3 to 17 years with Staphylococcus infection in tonsils, nose, ears were kept under medical surveillance. ASA and EHF therapies were instituted according to the developed schemes of such therapies. Positive dynamics was shown of clinical picture and parameters characterizing humoral and cell-mediated immunity. There were no unfavourable side-effects. The proposed mode of treatment can, we believe, be widely used in a clinical setting.
Marushko
Iu V
IuV
D000293:Adolescent; D000327:Adsorption; D000917:Antibody Formation / Q000187:drug effects / Q000528:radiation effects; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D005490:Focal Infection / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000528:radiation effects; D008297:Male; D008872:Microwaves / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000276:immunology* / Q000628:therapy*; D013208:Staphylococcal Toxoid / Q000627:therapeutic use
D013208:Staphylococcal Toxoid
Korektsiia imunitetu u pidlitkiv i diteĭ z vohnyshchevymy stafilokokovymy zakhvoriuvanniamy.